knowledge -WSS

knowledge

author：leisure time 2025-09-27 09:59:17 - browse：85863

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

entertainment

focus

WSS

Anthony Fauci pushes back on GOP claims during Covid hearing

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Structure Therapeutics oral GLP

Fight over Supreme Court dialysis ruling puts kidney patients at risk

The most pressing bird flu mysteries scientists want answered

Washington mulls new rules to avert another Change Healthcare

explore

knowledge

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

States should stop sabotaging methadone treatment reform

Tori Bowie and the unacceptable rates of Black maternal death

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

How to save PrEP access — and even expand it

Eli Lilly’s Zepbound improved liver scarring in mid

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Elevance PBM president out as customers face prescription chaos

Duchenne breakthrough therapy leaves behind pioneering families

Abortion pill case raises question: who can sue the FDA?

leisure time

Scientists boost immune system in aging mice by making it youthful

Finland to offer bird flu vaccine to select groups of people, a possible global first

Data don't support strong claims for Covid

The Readout: Lenmeldy, GLP

Readout Newsletter: Merck, Vertex, and Viking updates

For pregnant people, addiction treatment shouldn't mean a call to child protective services

focus

entertainment

focus

hotspot